AJNR Am J Neuroradiol
- QUIGG M, Chernyavskiy P, Terrell W, Smetana R, et al
Clinical outcomes of dynamic [(18)F]-FDG PET in focal epilepsy: a prospective
early observational study.
AJNR Am J Neuroradiol. 2026 Sep 29:ajnr.A9657. doi: 10.3174/ajnr.A9657.
Ann Nucl Med
- CELIK A, Gultekin A, Sengoz T, Simsek FS, et al
Baseline Ga-68 PSMA PET/CT-derived volumetric parameters as predictors of
biochemical recurrence following radical prostatectomy.
Ann Nucl Med. 2026 Oct 1. doi: 10.1007/s12149-026-02292.
- OGURA D, Kanou M, Toyama T, Koyama K, et al
Assessment of heart-to-contralateral lung ratios in virtual planar images derived
from SPECT using (99m)Tc-pyrophosphate scintigraphy.
Ann Nucl Med. 2026 Sep 29. doi: 10.1007/s12149-026-02294.
- MORITA R, Norikane T, Yamato N, Yamamoto Y, et al
Comparative diagnostic performance of (1)(8)F-FLT and (1)(8)F-FDG PET for differentiating
primary CNS lymphoma from glioblastoma, IDH-wildtype.
Ann Nucl Med. 2026 Sep 27. doi: 10.1007/s12149-026-02295.
- DO AMARAL KM, Siqueira RM, Arab NA, Etchebehere E, et al
Comparison of metabolic variables in FDG PET/CT in rectal cancer patients who
achieved a complete or incomplete response following neoadjuvant
chemoradiotherapy.
Ann Nucl Med. 2026 Sep 26. doi: 10.1007/s12149-026-02285.
- KAYA EM, Esen Akkas B, Ulucay M, Aghazada F, et al
Is early imaging a pitfall? Effect of [(6)(8)Ga]Ga-PSMA PET/CT timing after biopsy on
SUVmax and adverse pathology prediction in low-to-intermediate risk prostate
cancer.
Ann Nucl Med. 2026 Sep 26. doi: 10.1007/s12149-026-02288.
- GIOVACCHINI G, Agrawal S, Marciano A, Theodore WH, et al
Assessing metabolic progression in temporal lobe epilepsy: biological and
methodological considerations.
Ann Nucl Med. 2026;40:1245-1252.
- MATSUMURA T, Nakajima K, Mizokami A, Wakabayashi H, et al
Comparison of automated bone scan indexes in patients with prostate cancer: aBSI
and BONENAVI.
Ann Nucl Med. 2026;40:1253-1261.
- NAKAJIMA K, Makida S, Okamura M, Kawashiri MA, et al
Energy spectrum-based correction of washout rates in dual-isotope
(123)I-BMIPP/(201)Tl imaging.
Ann Nucl Med. 2026;40:1197-1209.
Appl Radiat Isot
- AL ROWAILY M, Albakhiti S, Alasmari B, Alruwaili A, et al
Assessing the effectiveness of (18)F-Fluorocholine PET-CT as the leading imaging
technique compared to (99m)Tc-Sestamibi scans and ultrasonography for diagnosing
hyperparathyroidism.
Appl Radiat Isot. 2026;238:112936.
- MEISEL Z, Hamad G, Brandenburg K, Brune CR, et al
Thick-target yield of (65)Cu(alpha,n)(68)Ga near threshold and implications for
nuclear medicine, deep underground detector backgrounds, and nucleosynthesis.
Appl Radiat Isot. 2026;239:112956.
- ASLAM MN, Amjed N, Zubia K, Rafique MY, et al
Theoretical assessment and optimization of cyclotron production routes for
high-purity (110m)In for PET applications.
Appl Radiat Isot. 2026;239:112957.
Hum Brain Mapp
- TARRICONE C, Vallini G, Baron G, Facca M, et al
Unveiling Functional-Metabolic Synergy in the Healthy Brain: Multivariate
Integration of Dynamic [(18)F]FDG-PET and Resting-State fMRI.
Hum Brain Mapp. 2026;47:e70651.
J Cereb Blood Flow Metab
- SIBAHI A, Hosseini SA, Rahmouni N, Therriault J, et al
A longitudinal investigation of locus coeruleus norepinephrine system integrity
and cognitive performance across the Alzheimer's spectrum.
J Cereb Blood Flow Metab. 2026;46:2623-2633.
J Nucl Cardiol
- NANEISHVILI T, How WJ, Venetucci L, Arumugam P, et al
Serial Rubidium-82 PET-CT of the Apical Microvascular Response to Mavacamten in
Obstructive Hypertrophic Cardiomyopathy: A Case-Based Report.
J Nucl Cardiol. 2026 Oct 1:102981. doi: 10.1016/j.nuclcard.2026.102981.
- O'GORMAN KJ, Cohen YA, Bremner L, Mian Z, et al
Lateral Wall Heterogeneity in (13)N-Ammonia Positron Emission Tomography Scans in
Heart Transplant Patients.
J Nucl Cardiol. 2026 Oct 1:102978. doi: 10.1016/j.nuclcard.2026.102978.
- POURBEHI MR, Juweid ME, Jafari E, Jokar N, et al
FAPI PET Reveals Active Fibroblast-Driven Remodeling Beyond Infarct Scar.
J Nucl Cardiol. 2026 Oct 1:102979. doi: 10.1016/j.nuclcard.2026.102979.
J Nucl Med
- MAASS A, Garcia-Garcia B, Behrenbruch N, Schumann-Werner B, et al
Associations of [(18)F]PI-2620 Binding with Memory and Phosphorylated Tau 217 in
Cognitively Unimpaired Older Adults.
J Nucl Med. 2026;67:1652-1660.
- ELLS Z, Meyer C, Masri K, Ryhiner M, et al
Tumor and Organ Dose Estimates from (177)Lu-PSMA-617 Therapy in Patients with
Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase
2 Trial.
J Nucl Med. 2026 Jul 30:jnumed.126.272574. doi: 10.2967/jnumed.126.272574.
- CARAVACA J, Seo Y, Cabello J, Siegel SB, et al
Clinical Imaging of (225)Ac in a PET Scanner via Time-of-Flight Cascade gamma-Ray
Imaging.
J Nucl Med. 2026 Sep 30:jnumed.126.272594. doi: 10.2967/jnumed.126.272594.
- TRAUTWEIN NF, Spogis J, Reischl G, Calderon E, et al
Head-to-Head Comparison of Neuroblastoma Detection by [(64)Cu]GD2 PET and
[(123)I]MIBG SPECT.
J Nucl Med. 2026 Sep 30:jnumed.126.272350. doi: 10.2967/jnumed.126.272350.
- PIRES M, Gutschmayer S, Bergalla E, Chauvie S, et al
Fully Automated Segmentation of [(18)F]FDG and [(68)Ga]/[(18)F]PSMA PET/CT Images
via Data-Centric Deep Learning.
J Nucl Med. 2026 Sep 30:jnumed.126.272852. doi: 10.2967/jnumed.126.272852.
- LIN W, Chen J, Ran W, Xu H, et al
Nectin-4-Targeted PET/CT Before Organ-Sacrificing Surgery for Occult Ureteral
Carcinoma.
J Nucl Med. 2026 Sep 30:jnumed.126.273397. doi: 10.2967/jnumed.126.273397.
- GODARA ML, Tekin V, Houson HA, Dufour G, et al
Evaluation of the In Vivo PET Generator (140)Nd/(140)Pr Using a HER2-Targeting
Agent.
J Nucl Med. 2026 Sep 30:jnumed.126.272952. doi: 10.2967/jnumed.126.272952.
-
Advancing Nuclear Medicine Through Patient Voices.
J Nucl Med. 2026;67:4A.
Neurology
- SHIR D, Algeciras-Schimnich A, Piura YD, Bornhorst JA, et al
Clinical Factors Associated With Discordant Plasma P-Tau217 and Established
Alzheimer Disease Biomarkers.
Neurology. 2026;107:e218591.
Nucl Med Commun
- ENISELER EB, Ekinci F, Sahbazlar M, Erdogan AP, et al
PET-derived metabolic-immunonutritional SUVmax-lactate
dehydrogenase-albumin-lymphocyte index for survival prediction in human epidermal
growth factor receptor 2-positive metastatic breast cancer receiving
pertuzumab-based therapy.
Nucl Med Commun. 2026 Sep 29. doi: 10.1097/MNM.0000000000002237.
- YAN G, Hu N, Ran M, Liu S, et al
PET/CT-based deep learning for differentiating squamous cell carcinoma from
adenocarcinoma in non-small cell lung cancer: comparison of multimodal fusion
strategies.
Nucl Med Commun. 2026 Sep 24. doi: 10.1097/MNM.0000000000002236.
- JIANG F, Liu S, Liu C, Zhang W, et al
18F-FDG PET/CT radiomics for prediction of BRCA mutations in high-grade serous
ovarian cancer.
Nucl Med Commun. 2026 Sep 22. doi: 10.1097/MNM.0000000000002245.
Phys Med Biol
- ZENG T, Najmaoui Y, Zhang J, Volpi T, et al
Impact of depth-of-interaction and spatially-variant point-spread-function model
on the performance of ultra-high resolution brain PET.
Phys Med Biol. 2026 Oct 2. doi: 10.1088/1361-6560.
- ZHANG Q, Liu Z, Deng T, Chen J, et al
Decay-time correction for dual-panel in-beam PET monitoring of carbon-ion SOBP
irradiation.
Phys Med Biol. 2026 Oct 1. doi: 10.1088/1361-6560.
- BUI MHH, Robert A, Badel JN, Etxebeste A, et al
Detection and correction of rigid patient motion in SPECT with exponential data
consistency conditions.
Phys Med Biol. 2026 Sep 29. doi: 10.1088/1361-6560.
Proc Natl Acad Sci U S A
- TOMASI D, Volkow ND
Reproducible cortical links between functional hierarchy, structure, and
metabolism.
Proc Natl Acad Sci U S A. 2026;123:e2614926123.
- ZOGHBI SS, Innis RB
Potential vascular confound in GPR84-PET imaging following systemic LPS
administration.
Proc Natl Acad Sci U S A. 2026;123:e2619004123.
- KALITA M, Kuo RC, Reyes ST, Scott PJH, et al
Reply to Zoghbi and Innis: Clarifying the cellular basis of GPR84-PET signal in
neuroinflammation.
Proc Natl Acad Sci U S A. 2026;123:e2623658123.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016